Literature DB >> 24643889

Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives.

Marco Guazzi1.   

Abstract

Entities:  

Keywords:  heart failure preserved ejection fraction; pulmonary hypertension; right ventricular function

Mesh：

Year:  2014        PMID： 24643889     DOI： 10.1161/CIRCHEARTFAILURE.113.000823

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  33 in total

1.  Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Authors:  Jason M Elinoff; Richa Agarwal; Christopher F Barnett; Raymond L Benza; Michael J Cuttica; Ahmed M Gharib; Michael P Gray; Paul M Hassoun; Anna R Hemnes; Marc Humbert; Todd M Kolb; Tim Lahm; Jane A Leopold; Stephen C Mathai; Vallerie V McLaughlin; Ioana R Preston; Erika B Rosenzweig; Oksana A Shlobin; Virginia D Steen; Roham T Zamanian; Michael A Solomon
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

2.  Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fraction.

Authors:  Mário Santos; Alexander R Opotowsky; Amil M Shah; Julie Tracy; Aaron B Waxman; David M Systrom
Journal:  Circ Heart Fail       Date:  2014-12-30       Impact factor: 8.790

Review 3.  Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.

Authors:  Yen-Chun Lai; Longfei Wang; Mark T Gladwin
Journal:  J Physiol       Date:  2018-12-30       Impact factor: 5.182

4.  Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction.

Authors:  Qingqing Meng; Yen-Chun Lai; Neil J Kelly; Marta Bueno; Jeffrey J Baust; Timothy N Bachman; Dmitry Goncharov; Rebecca R Vanderpool; Josiah E Radder; Jian Hu; Elena Goncharova; Alison M Morris; Ana L Mora; Steven D Shapiro; Mark T Gladwin
Journal:  Am J Respir Cell Mol Biol       Date:  2017-04       Impact factor: 6.914

Review 5.  Management of pulmonary hypertension due to heart failure with preserved ejection fraction.

Authors:  Manreet Kanwar; Ryan J Tedford; Richa Agarwal; Megan M Clarke; Claire Walter; George Sokos; Srinivas Murali; Raymond L Benza
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

6.  Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.

Authors:  Rebecca R Vanderpool; Melissa Saul; Mehdi Nouraie; Mark T Gladwin; Marc A Simon
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

Review 7.  The Heart Failure with Preserved Ejection Fraction Conundrum-Redefining the Problem and Finding Common Ground?

Authors:  P Iyngkaran; M C Thomas; C Neil; M Jelinek; M Cooper; J D Horowitz; D L Hare; D M Kaye
Journal:  Curr Heart Fail Rep       Date:  2020-04

8.  Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease.

Authors:  Hang Zhang; Juan Zhang; Du-Jiang Xie; Xiaoming Jiang; Feng-Fu Zhang; Shao-Liang Chen
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

9.  SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.

Authors:  Yen-Chun Lai; Diana M Tabima; John J Dube; Kara S Hughan; Rebecca R Vanderpool; Dmitry A Goncharov; Claudette M St Croix; Adolfo Garcia-Ocaña; Elena A Goncharova; Stevan P Tofovic; Ana L Mora; Mark T Gladwin
Journal:  Circulation       Date:  2016-01-26       Impact factor: 29.690

10.  Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.

Authors:  Longfei Wang; Gunner Halliday; Joshua R Huot; Taijyu Satoh; Jeffrey J Baust; Amanda Fisher; Todd Cook; Jian Hu; Theodore Avolio; Dmitry A Goncharov; Yang Bai; Rebecca R Vanderpool; Robert V Considine; Andrea Bonetto; Jiangning Tan; Timothy N Bachman; Andrea Sebastiani; Charles F McTiernan; Ana L Mora; Roberto F Machado; Elena A Goncharova; Mark T Gladwin; Yen-Chun Lai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-09       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.